Sector: MedicalInspire Pharmaceuticals, Inc. (NASDAQ: ISPH)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 175 |
Technical : | 228 |
Performance : | 258 |
Overall: | 264 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 177 |
Technical : | 216 |
Performance : | 122 |
Overall: | 198 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 197 |
Technical : | 188 |
Performance : | 231 |
Overall: | 254 |
Number of Stocks: | 306 |
Headlines
- Inspire Announces Webcast of Presentation at Piper Jaffray Health Care Conference
Nov 25, 2009 07:00 AM | ISPH, PJC
- Inspire Reports Third Quarter 2009 Financial Results
Nov 05, 2009 07:01 AM | ISPH
- Groundbreaking Leadership Roundtable Draws Top CEOs
Oct 27, 2009 11:35 AM | ISPH
- Inspire's President and CEO Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award
Oct 20, 2009 09:00 AM | ISPH
- RidgewaterEquity.com Free Fundamental Sector & Market Research on GRT, ISPH, AVGO, MLHR, HYTM and BNVI
Oct 20, 2009 06:53 AM | GRT, ISPH, MLHR
- Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Oct 15, 2009 07:00 AM | ISPH
- AzaSite(R) Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage
Sep 14, 2009 04:03 PM | ISPH
- Inspire Committed to Helping Healthcare Providers and Patients During Erythromycin Ophthalmic Ointment Shortage
Sep 09, 2009 04:00 PM | ISPH
- Inspire Wins North Carolina Health & Life Sciences Award for Cystic Fibrosis Development Program
Sep 09, 2009 07:00 AM | ISPH
- Inspire Announces Webcasts of Presentations at Morgan Stanley, BioCentury and UBS Healthcare Conferences
Sep 08, 2009 07:00 AM | ISPH, MS, UBS
- InSite Vision Reports Third Quarter 2009 Financial Results
Nov 11, 2009 04:51 PM | ISPH, PFE
- InSite Vision to Hold Annual Meeting of Stockholders
Oct 07, 2009 05:50 PM | ISPH, PFE
- Inspire Announces Closing of $115 Million Public Offering
Aug 10, 2009 04:03 PM | ISPH
- Inspire Announces Pricing of $100 Million Common Stock Offering
Aug 05, 2009 09:51 AM | ISPH
- Inspire Announces Public Offering of Common Stock
Aug 04, 2009 04:06 PM | ISPH
- Inspire Reports Second Quarter 2009 Financial Results
Jul 31, 2009 09:51 AM | ISPH
- Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2009 Financial Results
Jul 28, 2009 07:12 AM | ISPH
- Inspire’s Thomas Staab Named CFO of the Year by Triangle Business Journal
Jul 21, 2009 07:04 AM | ISPH
- Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
Jun 12, 2009 07:02 AM | ISPH
- Inspire Announces Webcast of Presentation at Needham Life Sciences Conference
Jun 04, 2009 04:01 PM | ISPH
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: SHAFFER CHRISTY L (10K)
Nov 13, 2009 03:33 PM
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: Brazzell Romulus K (10K)
Nov 13, 2009 03:33 PM
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: SCHACHLE JOSEPH K (10K)
Nov 13, 2009 03:32 PM
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: Spagnardi Joseph M (10K)
Nov 13, 2009 03:32 PM
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: STAAB THOMAS R II (10K)
Nov 13, 2009 03:28 PM
- Form 4 INSPIRE PHARMACEUTICALS For: Nov 11 Filed by: YERXA BENJAMIN R (10K)
Nov 13, 2009 03:28 PM
- Form 4 YERXA BENJAMIN R For: Nov 02 (10K)
Nov 03, 2009 02:10 PM
- Form 4 YERXA BENJAMIN R For: Oct 01 (10K)
Oct 01, 2009 06:22 PM
- Form 4 YERXA BENJAMIN R For: Sep 01 (10K)
Sep 01, 2009 06:41 PM
- Form 4 SHAFFER CHRISTY L For: Aug 24 (10K)
Aug 25, 2009 04:43 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ISPH
|
Compare to S&P
|
| YTD |
40.00 %
|
15.87 %
|
| 4 Weeks |
-7.01 %
|
-8.01 %
|
| 12 Weeks |
-17.78 %
|
-22.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 29.41 %
|
|
EPS Growth in Last Year: 29.41 %
|
|
Sales Growth in Last Quarter: 9.18 %
|
|
Sales Growth in Last Quarter: 26.14 %
|
|
